PR Vade-mécum Brasil 2026

Clyna S.A.

About this app

PR Vade-mécum Brasil brings together all relevant information related to pharmaceutical products.

PR Vade-mécum was developed from trusted sources, such as the manufacturing companies and the medical-pharmacological bibliography available in the country and abroad.

The application allows you to access the following indexes:

- Products
The text of the bulls contains two products marketed in Brazil.

- Laboratories

- Pathologies

- Interactions

- Pharmacological Index

- Therapeutic Index

- I.S.P.R. Index of Related Substances and Products

Responsibility statement:

THIS APPLICATION DOES NOT REPRESENT A GOVERNMENT ENTITY.

The PR Vademecum should not be considered as an autonomous and sufficient means to prescribe the medications or substances about which it informs; Your recipients should use it as a complement to their non-delegated professional responsibility, making them aware that the reader has the knowledge necessary to interpret the information provided by this application.

What’s new

O conteúdo dos seguintes produtos foi atualizado:

ACETILCISTEÍNA NEO QUIMICA
AMOXICILINA MULTILAB
AVITAMINA D 3
BESILATO DE LEVANLODIPINO EMS
BESILATO DE LEVANLODIPINO GEN GERMED
BIZO
BRONFENIRAMINA + FENILEFRINA ACHÉ
BUDESONIDA + FORMOTEROL ACHÉ
CAPTOPRIL NOVA QUIMICA
CIPROFIBRATO MEDQUIMICA
DECONGEX
DICLORIDRATO DE TRIMETAZIDINA EMS
EMPAGLIFLOZINA MEDQUIMICA
FUEBLO
HEMIFUMARATO DE BISOPROLOL EUROFARMA
LOZEPREL
MEXY
NISBAL
ONADYV
PAMFER
PANTOGAR ÔMEGA
UNDECILATO DE TESTOSTERONA NEO QUIMICA
VOD